Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Acute Lymphocytic Leukemia Pipeline Drugs Market Report Overview
Acute lymphocytic leukemia (ALL) is a cancer of the white blood cells due to the production of a large number of immature lymphocytes thus blocking the production of normal blood cells. Risk factors for ALL include exposure to radiation or chemicals, age, virus infections, and genetic factors. Symptoms include anemia, frequent infections, easy bruising, bone pain, and breathing problems. Treatment includes chemotherapy, transfusions, transplant, and medications.
The ALL pipeline drugs market research report provides comprehensive information on the therapeutics under development for ALL, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report offers an overview of key players involved in therapeutic development for ALL and features dormant and discontinued projects.
ALL Pipeline Drugs Market Segmentation by Targets
Some of the targets of the ALL pipeline drugs market are Cells Expressing B Lymphocyte Antigen CD19, Cells Expressing B Cell Receptor CD22, Cells Expressing T Cell Antigen CD7, Asparagine, Bcr-Abl Tyrosine Kinase, and others.
ALL Pipeline Drugs Market Analysis, by Targets
For more ALL pipeline drugs market target insights, download a free report sample
ALL Pipeline Drugs Market Segmentation by Mechanisms of Action
Some of the key mechanisms of action of the ALL pipeline drugs market are Cytotoxic To Cells Expressing B Lymphocyte Antigen CD19, Cytotoxic To Cells Expressing B Cell Receptor CD22, Cytotoxic To Cells Expressing T Cell Antigen CD7, Bcr-Abl Tyrosine Kinase Inhibitor, Asparagine Depletor, and others.
ALL Pipeline Drugs Market Analysis, by Mechanisms of Action
For more mechanisms of action insights into the ALL pipeline drugs market, download a free report sample
ALL Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the ALL pipeline drugs market are intravenous, parenteral, oral, subcutaneous, intratumor, and others.
ALL Pipeline Drugs Market Analysis, by Routes of Administration
For more routes of administration insights into the ALL pipeline drugs market, download a free report sample
ALL Pipeline Drugs Market Segmentation by Molecule Types
The molecule types in the ALL pipeline drugs market are Gene-Modified Cell Therapy, Small Molecule, Monoclonal Antibody, Cell Therapy, Monoclonal Antibody Conjugated, and others.
ALL Pipeline Drugs Market Analysis, by Molecule Types
For more molecule type insights into the ALL pipeline drugs market, download a free report sample
ALL Pipeline Drugs Market - Competitive Landscape
Some of the key companies in the ALL pipeline drugs market are Novartis AG, Gracell Biotechnologies Inc, Pfizer Inc, Bristol-Myers Squibb Co, Hebei Senlang Biotechnology Co Ltd, PersonGen BioTherapeutics (Suzhou) Co Ltd, and others.
ALL Pipeline Drugs Market Analysis, by Companies
To know more about the ALL pipeline drugs market companies, download a free report sample
ALL Pipeline Drugs Market Report Overview
Key Targets | Cells Expressing B Lymphocyte Antigen CD19, Cells Expressing B Cell Receptor CD22, Cells Expressing T Cell Antigen CD7, Asparagine, Bcr-Abl Tyrosine Kinase, and Others |
Key Mechanisms of Action | Cytotoxic To Cells Expressing B Lymphocyte Antigen CD19, Cytotoxic To Cells Expressing B Cell Receptor CD22, Cytotoxic To Cells Expressing T Cell Antigen CD7, Bcr-Abl Tyrosine Kinase Inhibitor, Asparagine Depletor, and Others |
Key Routes of Administration | Intravenous, Parenteral, Oral, Subcutaneous, Intratumor, and Others |
Key Molecule Types | Gene-Modified Cell Therapy, Small Molecule, Monoclonal Antibody, Cell Therapy, Monoclonal Antibody Conjugated, and Others |
Key Companies | Novartis AG, Gracell Biotechnologies Inc, Pfizer Inc, Bristol-Myers Squibb Co, Hebei Senlang Biotechnology Co Ltd, PersonGen BioTherapeutics (Suzhou) Co Ltd, and Others |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of ALL.
- The pipeline guide reviews pipeline therapeutics for ALL by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in ALL therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates ALL therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for ALL
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counterstrategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for ALL.
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding the ALL pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understanding from the know-how what drove them from the pipeline.
Abclon Inc
Achelois Cell Therapy
Actinium Pharmaceuticals Inc
Actinobac Biomed Inc
ADC Therapeutics SA
Adienne Pharma & Biotech SA
Adlai Nortye Biopharma Co Ltd
Agastiya Biotech LLC
AIkido Pharma Inc
Aileron Therapeutics Inc
AIMM Therapeutics BV (Inactive)
Alaunos Therapeutics Inc
Allterum Therapeutics LLC
Amgen Inc
Angiocrine Bioscience Inc
Apexian Pharmaceuticals Inc
Arch Oncology Inc
Armaceutica Inc
Ascentage Pharma Group International
Ascentawits Pharmaceuticals Ltd
AstraZeneca Plc
Athenex Inc
Autolus Therapeutics Plc
Avalon GloboCare Corp
AvenCell Europe GmbH
AVM Biotechnology LLC
Ayala Pharmaceuticals Inc
Bayer AG
Beijing Immunochina Pharmaceuticals Co Ltd
Bellicum Pharmaceuticals Inc
Bio-Cancer Treatment International Ltd
Bio-Path Holdings Inc
Bioceltech Therapeutics Ltd
Biocure Technology Inc
Biohaven Pharmaceutical Holding Company Ltd
Biomea Fusion Inc
BlueSphere Bio Inc
Bristol-Myers Squibb Co
Calithera Biosciences Inc
Cambridge Innovation Technologies Consulting Ltd
Caribou Biosciences Inc
CARsgen Therapeutics Ltd
Cellectis SA
Cellestia Biotech AG
Cellular Biomedicine Group Inc
Celularity Inc
Centrymed Pharmaceutical Inc
Century Therapeutics Inc
Ceptur Therapeutics Inc
Changzhou Qianhong Bio-Pharma Co Ltd
Cheetah Cell Therapeutics Co Ltd
Chengdu USino Technology Biology Co Ltd
Chengdu Zenitar Biomedical Technology Co Ltd
Chimagen Biosciences Ltd
Chimeric Therapeutics Ltd
Chimerix Inc
China Immunotech (Beijing) Biotechnology Co Ltd
China Immunotech Co Ltd
Chongqing Precision Biotech Co Ltd
CoImmune Inc
ConverGene LLC
CRISPR Therapeutics AG
CSPC Pharmaceutical Group Ltd
Cullinan Oncology Inc
Curon Biopharmaceutical Ltd
Cyclacel Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
DEKK-TEC Inc
Delta-Fly Pharma Inc
DevaCell Inc
Diatheva srl
Diazon Pharmaceuticals Inc
DiNonA Inc
EdiGene Inc
Elf Zone Inc
Enzyme by Design Inc
Epizyme Inc
ERYTECH Pharma SA
Eureka Therapeutics Inc
Eutilex Co Ltd
ExCellThera Inc
Excelmab Inc
F. Hoffmann-La Roche Ltd
Fate Therapeutics Inc
Felicitex Therapeutics Inc
Fochon Pharmaceutical Ltd
Fusion Pharmaceuticals US Inc
Gamida Cell Ltd
Generium
Gilead Sciences Inc
Gracell Biotechnologies Inc
Guangzhou Bio-gene Technology Co Ltd
Hangzhou Minsheng Pharmaceutical Group Co Ltd
Hangzhou Qihan Biotechnology Co Ltd
Hebei Senlang Biotechnology Co Ltd
HemoGenyx Pharmaceuticals Plc
Henan Honghui Biotechnology Co Ltd
HighPass Bio Inc
Hillstream BioPharma Inc
HK inno.N Corp
Housey Pharmaceutical Research Laboratories LLC
HRAIN Biotechnology Co Ltd
Humanigen Inc
Hunan Siweikang Therapeutics Ltd
iCell Gene Therapeutics LLC
iDD biotech SAS
IGM Biosciences Inc
Iksuda Therapeutics Ltd
ImCheck Therapeutics SAS
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
ImmunityBio Inc
ImmunoAct Pvt Ltd
ImmunoGen Inc
Immunotech Biopharm Ltd
IN8bio Inc
Inatherys
Incyte Corp
Innate Pharma SA
InnoBation Bio
InnoCare Pharma Ltd
Interprotein Corp
Jazz Pharmaceuticals Plc
Jiangxi Shanxing Biotechnology Co Ltd
Johnson & Johnson
Juventas Cell Therapy Ltd
Karyopharm Therapeutics Inc
Kecellitics Biotech Co Ltd
Kenjockety Biotechnology Inc
Kiromic BioPharma Inc
Kronos Bio Inc
Kymera Therapeutics Inc
Legend Biotech Corp
LegoChem Biosciences Inc
Les Laboratoires Servier SAS
Light Chain Bioscience
Lin Bioscience Inc
Luminary Therapeutics Inc
MAA Laboratories Inc
MacroGenics Inc
Mana Therapeutics Inc
MannKind Corp
ManysmarT Therapeutics Inc
Marker Therapeutics Inc
medac GmbH
MediSix Therapeutics Pte Ltd
MedPacto Inc
Merck & Co Inc
Meryx Inc
Millennium Pharmaceuticals Inc
Miltenyi Biomedicine GmbH
Mito BioPharm LLC
Molecular Templates Inc
Nabriva Therapeutics Plc
Nanjing Bioheng Biotech Co Ltd
Nanjing CART Medical Technology Co Ltd
Nanjing Iaso Biotherapeutics Co Ltd
Nanjing KAEDI Biotech Inc
Nanocopoeia LLC
NanoValent Pharmaceuticals Inc
Nektar Therapeutics
Newave Pharmaceutical Inc
Nkarta Inc
Nohla Therapeutics Inc
Novartis AG
NovoMedix LLC
Omeros Corp
Onconova Therapeutics Inc
OncoSynergy Inc
OncoTartis Inc
OneChain Immunotherapeutics
Orca Biosystems Inc
Orgenesis Inc
Oxcia AB
Pascal Biosciences Inc
PentixaPharm GmbH
PeproMene Bio Inc
PersonGen BioTherapeutics (Suzhou) Co Ltd
Pfizer Inc
Pharma Mar SA
PharmaEssentia Corp
Pinotbio Inc
Porton Biopharma Ltd
PPD Australia Pty Ltd
Precigen Inc
Precision Biosciences Inc
Provectus Biopharmaceuticals Inc
PTC Therapeutics Inc
Regenacy Pharmaceuticals LLC
Regeneron Pharmaceuticals Inc
ReguGene Co Ltd
Retrotherapy LLC
Ryvu Therapeutics SA
Sabz Biomedicals
Sana Biotechnology Inc
Sanofi
Sareum Holdings Plc
SciTech Development LLC
SELLAS Life Sciences Group Inc
Shandong New Time Pharmaceutical Co Ltd
Shanghai Biomed-Union Biotechnology Co Ltd
Shanghai Bioray Laboratory Inc
Shanghai GeneChem Co Ltd
Shanghai Keqi Pharmaceutical Technology Co Ltd
Shanghai Longyao Biotechnology Co Ltd
Shanghai Pharmaceuticals Holding Co Ltd
Shanghai Simnova Biotechnology Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Shanghai YaKe Biotechnology Co Ltd
Shenzhen BinDeBio Ltd
Shorla Pharma Ltd
SinoCelltech Group Ltd
Smart Immune SAS
Sorrento Therapeutics Inc
SpecificiT Pharma Inc
Sumitomo Pharma Co Ltd
Sun Pharma Advanced Research Company Ltd
Sunnycell Therapeutics Ltd
SunRock Biopharma SL
Suzhou Fundamenta Therapeutics Co Ltd
Synaptogenix Inc
Syncopation Life Sciences Inc
Syndax Pharmaceuticals Inc
SYNIMMUNE GmbH
Systimmune Inc
Tacitus Therapeutics Inc
Takara Bio Inc
Takeda Pharmaceutical Co Ltd
TC BioPharm Ltd
TCR2 Therapeutics Inc
Telix Pharmaceuticals Ltd
Tianjin Mycure Medical Technology Co Ltd
Tianweiyuan and Biomedicine Shanghai Co Ltd
TotalClarity Inc
Triphase Accelerator Corp
TScan Therapeutics Inc
UWELL Biopharma Inc
Vincerx Pharma Inc
VioQuest Pharmaceuticals Inc (Inactive)
Wellington Zhaotai Therapies Ltd
Wugen Inc
Wuhan Bio-Raid Biotechnology Co Ltd
Wyze Biotech Co Ltd
Xbrane Biopharma AB
Xencor Inc
Xi'An Yufan Biotechnology Co Ltd
Xiamen Nuokang Biotechnology Co Ltd
Xspray Pharma AB
Zhejiang Teruisi Pharmaceutical Co Ltd
Zhuobo Yong Ji (Shanghai) Biological Pharmaceutical Co Ltd
Zovis Pharmaceuticals
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets of the ALL pipeline drugs market?
Some of the targets of the ALL pipeline drugs market are Cells Expressing B Lymphocyte Antigen CD19, Cells Expressing B Cell Receptor CD22, Cells Expressing T Cell Antigen CD7, Asparagine, Bcr-Abl Tyrosine Kinase, and others.
-
What are the key mechanisms of action in the ALL pipeline drugs market?
Some of the mechanisms of action of the ALL pipeline drugs market are Cytotoxic To Cells Expressing B Lymphocyte Antigen CD19, Cytotoxic To Cells Expressing B Cell Receptor CD22, Cytotoxic To Cells Expressing T Cell Antigen CD7, Bcr-Abl Tyrosine Kinase Inhibitor, Asparagine Depletor, and others.
-
What are the key routes of administration in the ALL pipeline drugs market?
The key routes of administration in the ALL pipeline drugs market are intravenous, parenteral, oral, subcutaneous, intratumor, and others.
-
What are the key molecule types in the ALL pipeline drugs market?
The molecule types in the ALL pipeline drugs market are Gene-Modified Cell Therapy, Small Molecule, Monoclonal Antibody, Cell Therapy, Monoclonal Antibody Conjugated, and others.
-
Which are the leading companies in the ALL pipeline drugs market?
Some of the leading companies in the ALL pipeline drugs market are Novartis AG, Gracell Biotechnologies Inc, Pfizer Inc, Bristol-Myers Squibb Co, Hebei Senlang Biotechnology Co Ltd, PersonGen BioTherapeutics (Suzhou) Co Ltd, and others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.